See also stories tagged with Cancer
Search results for memorial sloan kettering cancer center
Cancer patients and doctors report drug side effects differently
Nov 17, 2009 |
not rated yet |
0
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, ...
PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients
Dec 02, 2009 |
not rated yet |
0
Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related ...
Genetic abnormality may increase risk of blood disorders
Mar 15, 2009 |
not rated yet |
0
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited. Their research, published online today in Nature Genetics, identi ...
Prostate Cancer Surgery Performed by Many Surgeons with Little Experience
Nov 19, 2009 |
not rated yet |
0
(PhysOrg.com) -- A new study from researchers at Memorial Sloan-Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially ...
Therapeutic cloning treats Parkinson's disease in mice
Mar 23, 2008 |
3.6 / 5 (8) |
0
Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice. The ...
Genes set scene for metastasis
Apr 11, 2007 |
4.7 / 5 (3) |
0
Biologists at Memorial Sloan-Kettering Cancer Center (MSKCC) have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor. ...
$100 million gift given to fight cancer
Sep 22, 2006 |
3 / 5 (2) |
0
The Starr Foundation has donated $100 million to promote cancer research at four New York institutions and one in Massachusetts.
Surgery not necessary for most late-stage colorectal cancers
May 31, 2009 |
5 / 5 (1) |
0
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers ...
Research reveals what drives lung cancer's spread
Jul 02, 2009 |
4.5 / 5 (2) |
1
(PhysOrg.com) -- A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the ...
Study shows drug combination improves outcome for advanced non-small cell lung cancer
May 31, 2009 |
5 / 5 (1) |
0
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). Results from the Phase III "ATLAS" trial were presented today by ...
Researchers identify new genetic marker for breast cancer
Mar 03, 2008 |
5 / 5 (3) |
0
An international group of investigators led by scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this ...
Prostate Cancer Treated Using Microfluidics Technology
Oct 06, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- By analyzing rare tumor cells in patient's blood, using a special microchip, doctors would be able to predict how a patient will respond to drug treatment. By using microfluidics technology ...
Breast cancer risk varies among women who are carriers of BRCA1 and BRCA2 gene mutations
Jan 08, 2008 |
not rated yet |
0
Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the
New study examines effectiveness of colorectal cancer screening tests
Oct 07, 2008 |
1 / 5 (1) |
0
New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients ...
Genes found to play a role in breast cancer's spread to the brain
May 06, 2009 |
5 / 5 (1) |
0
New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms ...
